NeladalkibTFA is the TFA salt form of Neladalkib. Neladalkib (NVL-655) is an orally available ALK inhibitor, exhibiting an IC50 of 2.8 nM against ALK. It induces apoptosis and demonstrates antitumor activity.
Target:
ALK|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
